Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT in healthy subjects
NL-OMON60406Phase 1Completed
- Sponsor
- Algernon Pharmaceuticals Inc.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of DMT in stroke, sponsored by Algernon Pharmaceuticals Inc. Started Nov 2022; status: completed.
02
Drugs
DMT
03
Conditions
stroke
Beyond the preview
Go deeper on NL-OMON60406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60406.